“True freedom is living and learning without fear.”
Deb Kelly is an esteemed Scientific Director and executive leader with a distinguished career in biomedical research, preclinical and clinical program development, and cutting-edge technology. With over 15 years of experience, she has spearheaded transformative projects in cancer research, viral health threats, and drug discovery, integrating artificial intelligence, bioinformatics, and statistical analysis to drive groundbreaking advancements in translational medicine.
As the Executive Director of Structural Oncology LLC and a long-standing career as a university professor, Kelly has led multidisciplinary teams in high-impact research that combines computational modeling, high-resolution imaging, and predictive analytics. Her expertise extends to managing large genomic datasets, providing clinical decision support, and optimizing translational medicine through health economics and outcomes research. She has successfully mentored over 15 early-career professionals, fostering a culture of scientific excellence and innovation.
Kelly’s leadership is marked by her ability to navigate complex biomedical challenges while securing substantial funding to advance scientific discovery. She has managed external federal funds amounting to $1.2 million annually and has secured over $7 million in research funding within the past six years. Her work has resulted in significant contributions to proteomic datasets, therapeutic development, and patent-backed innovations to advance our understanding of human health and disease.
Her academic tenure at leading medical centers has been defined by her commitment to teaching, mentorship, and curriculum development. She has played a pivotal role in training the next generation of scientists and medical professionals, guiding students through complex research projects that have led to prestigious residency placements and high-impact publications. Her leadership extends beyond academia, holding key roles such as President of the Microscopy Society of America and Chair of the MSFB study section at the NIH.
With a Ph.D. in Molecular Biophysics from Florida State University and advanced training at Harvard Medical School, Kelly’s academic foundation has been instrumental in her ability to bridge fundamental research with real-world medical applications. Her pioneering work in artificial intelligence-driven drug discovery continues to shape the future of biomedical research.
Beyond her professional achievements, Kelly remains actively engaged in scientific advisory boards, research leadership committees, and community outreach programs. An accomplished athlete, she finds balance through marathon running, tennis, and pickleball, embodying the discipline and resilience that define her career. With a passion for innovation and mentorship, Deb Kelly remains committed to advancing biomedical science and improving human health through cutting-edge translational research.
Character
Deb Kelly is a visionary leader with a deep commitment to scientific discovery and mentorship, fostering innovation while guiding early-career professionals to success. Her integrity, resilience, and dedication to advancing biomedical research reflect her unwavering passion for improving the healthcare system.
Knowledge
With expertise spanning molecular biophysics, computational modeling, and therapeutic targeting, Kelly integrates cutting-edge technologies into translational medicine. Her ability to analyze complex biomedical data and apply predictive measures has led to groundbreaking advancements in cancer research and drug discovery.
Strategic
Kelly excels at securing funding, managing large-scale research initiatives, and leading multidisciplinary teams to drive scientific breakthroughs. Her strategic approach to integrating artificial intelligence, bioinformatics, and health economics ensures long-term impact in biomedical research and clinical applications.
Communication
A skilled communicator, Kelly effectively conveys complex scientific concepts to diverse audiences, from academic institutions to industry leaders. Her mentorship, teaching, and leadership roles demonstrate her ability to inspire collaboration and advance scientific innovation through clear and impactful communication.
